Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
OF
DRUG
BRAND
NAME:
Ferrogr
ad folic
GENERI
C
NAME:
Ferrous
Sulfate
+ Folic
acid
MECHANIS
M OF
ACTION
Ferrous
sulphat
e
It
works
by
replaci
ng iron
in your
body if
your
body
does
not
produc
e
enough
on its
own.
Folic
acid
helps
your
body
produc
e and
maintai
n new
cells,
CLASSIFICA
TION
Antiane
mic
DOSAGE
200
mg
500
mg
One
tab
per
day
INDICATION
CONTRAIND
ICA-TION
ADVERS
EFFECT
Treating
anemia
caused
by low
levels of
iron or
folate in
the
blood.
It
replaces
iron in
the body
when the
body
does not
produce
enough
on its
own.
Contrain
dicated
in
patients
who
have
experien
ced with
paroxys
mal
nocturna
l
hemoglo
binuria
(hemogl
obin in
the
urine,
especiall
y
observe
d in the
morning
as dark
colored
urine),
GI:
discomf
ort,
heart
burn,
loss of
appetite
,
nausea,
vomitin
g,
constipa
tion,
diarrhea
. Stool
darkeni
ng or
bloody
stool
may
occur.
NURSING
RESPONSIBILITY
Advise patient
to take ferrous
fumarate/folic
acid with a full
glass of water
Do not lie down
for 30 minutes
after taking
ferrous
fumarate/folic
acid
Take ferrous
fumarate and
folic acid on an
empty
stomach, at
least 1 hour
before or 2
hours after a
meal
If you miss a
dose of ferrous
fumarate/folic
acid, take it as
and
also
helps
preven
t
change
s
to
DNA
that
may
lead to
cancer.
accumul
ation of
iron, and
excess
iron in
the body
soon as
possible. If it is
almost time for
your next dose,
skip the missed
dose and go
back to your
regular dosing
schedule. Do
not take 2
doses at once
Tell the patient
that Ferrous
fumarate/folic
acid may cause
darkened or
green stools.
This is normal
and not a cause
for concern
Do NOT take
more than the
recommended
dose without
checking with
your doctor
NAME
OF
DRUG
BRAND
NAME:
motilliu
m
GENERI
C
NAME:
Domper
idone
MECHANIS
M OF
ACTION
CLASSIFIC
A -TION
DOSAGE
INDICATION
CONTRAIND
ICA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
Domperi
done acts
as a
gastroint
estinal
emptying
(delayed)
adjunct
and
peristalti
c
stimulant
.
Domperi
done
facilitates
gastric
emptying
and
decrease
s small
bowel
transit
time by
increasin
g
esophage
al and
Antido
pamine
rgic
Antiem
etic
10 ug
one
tab 3
times
a day
For
manage
ment of
dyspepsi
a,
heartburn
,
epigastric
pain,
nausea,
and
vomiting.
Contrain
dicated
in
patients
with
known
sensitivit
y
or intoler
ance to
the drug.
rash
Itching
headach
e
dry
mouth
dizzines
s
nervous
ness
irritabilit
y
leg
cramps
gastric
peristalsi
s and by
lowering
esophage
al
sphincter
pressure.
NAME
OF
DRUG
BRAND
NAME:
Cozaar
Arbloc
GENER
IC
NAME:
Losart
an
MECHANISM
OF ACTION
CLASSIFICATI
ON
DOSAGE
INDICATION
CONTRAINDI
CA-TION
Losartan
(more
specificall
y, the
chemical
formed
when
the liver c
onverts
the
inactive
losartan
into its
active
form)
blocks
the
angiotens
in
receptor.
By
blocking
the
action of
angiotens
in,
losartan
relaxes
Angiote
nsin II
receptor
blocker
100m
g tab
once a
day
Treatme
nt of
diabetic
nephrop
athy in
type 2
diabetes
with
hyperten
sion
Contraind Upper
icated in
Respirat
patient
ory
who are
Tract
diabetic
Infectio
and
n
taking ali Dizzines
s
skiren
Insomni
a
Muscle
Cramps
Leg Pain
Hyperka
lemia
Angioed
ema
Orthost
atic
Hypoten
sion
ADVERS
EFFECT
NURSING
RESPONSIBILITY
Assess
patients
renal function
Administer
without regard
to meals.
Monitor patients
BP.
Monitor
patients who
are also taking
diuretics
for symptomat
ic
hypotension.
Tell patient to
avoid
salt substitute
s
Monitor
patient closely
in any
muscle
cells and
dilates
blood
vessels
thereby
reducing
blood
pressure.
NAME
OF
DRUG
MECHANISM
OF ACTION
situation that
may lead to a
decrease in
blood pressure
secondary to
reduction in
fluid volume
excessive
perspiration,
dehydration,
vomiting, and
diarrhea
excessive
hypotension
can occur.
CLASSIFI
CA-TION
DOSAGE
INDICATION
CONTRAIND
ICA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
BRAND
NAME:
Norvasc
Amvasc
BE
GENERI
C NAME:
Amlodipi
ne
Inhibits
the
movemen
t of
calcium
ions
across the
membran
es of
cardiac
and
arterial
muscle
cells;
inhibits tr
ansmemb
rane calci
um flow,
which
results in
the
depressio
n of
impulse
formation
in
specialize
d cardiac
pacemake
Calciu
m
chann
elblock
er
Antia
nginal
drug
Antih
ypert
ensiv
e
Initiall
y,
5 mg
PO
daily
Dosa
ge
may
be
gradu
ally
increa
sed
over
1014
days
to a
maxi
mum
dose
of
10 m
g PO
daily.
Angina
pectoris
due to
coronary
artery
spasm
Chronic
stable
angina,
alone or
in
combinati
on with
other
agents
Essential
hyperten
sion,
alone or
in
combinati
on with
other anti
hyperten
sives
Contrain
dicated
with
allergy
to amlod
ipine,
impaired
hepatic
or renal
function,
sick
sinus
syndrom
e, heart
block
(second
or third
degree),
and
lactation
.
Use
cautiousl
y with
CHF,
pregnan
cy.
CNS:
Dizzines
s, lightheaded
ness,
headach
e, asthe
nia, fati
gue,
lethargy
CV:
Peripher
al
edema,
arrhyth
mia
Dermat
ologic:
Flushing
, rash
GI: Nau
sea, abd
ominal
discomf
ort
Monitor
patient
carefully (BP,
and output)
while
adjusting
drug to
therapeutic
dose.
Monitor
cardiac
rhythm
regularly
during
stabilization
of dosage
and
periodically
during longterm therapy.
Administer
drug without
regard to
meals but
take with
meals if
r cells,
slowing of
the
velocity of
conductio
n of the
cardiac
impulse,
depressio
n of
myocardia
l
contractili
ty, and
dilation of
coronary
arteries
and
arterioles
and
peripheral
arterioles;
these
effects
lead to
decreased
cardiac
work,
decreased
upset
stomach
occurs.
Advised the
S.O. if the
patient
experience
these side
effects:
Nausea,
vomiting (eat
frequent
small meals);
headache
(adjust
lighting,
noise, and
temperature;
medication
may be
ordered).
Instructed
the S.O. to
report
irregular
heartbeat,
cardiac
oxygen
consumpti
on, and in
patients
with vasos
pastic (Pri
nzmetals)
angina,
increased
delivery of
oxygen to
cardiac
cells.
shortness of
breath,
swelling of
the hands or
feet,
dizziness,
and
constipation.
NAME
OF
DRUG
BRAND
NAME:
Epogen
Procrit
GENERI
C
NAME:
Epoetin
Alfa
MECHANIS
M OF
ACTION
Mimics
the
effects
of
erythro
poietin
.
Functio
ns as a
growth
factor
and as
a
differe
ntiatin
g
factor,
enhanc
ing
RBC
produc
tion.
CLASSIFICA
TION
DOSAGE
INDICATION
CONTRAIND
ICA-TION
ADVERS
EFFECT
Erythrop
oietin
(human,
recombi
nant)
4000
IU/ SC
twice
a
week
Anemia
in chronic
renal
failure
(CRF)
Anemia
related to
zidovudin
e in HIVinfected
patients.
Contrain
dicated
to
patient
with
uncontro
lled
hyperten
sion.
Iron
Deficienc
y
Hyperten
sion
Headach
e
Arthralgi
a
GI
Disturba
nces
Edema
Local
Reaction
Rash
Paresthe
sia
Dizziness
Clotted
Vascular
Access
(A-V
Shunt)
Respirat
ory
Congesti
NURSING
RESPONSIBILITY
Before
starting the
therapy
evaluate
patients iron
status
Assess
patient if feels
difficulty of
breathing or
shortness of
breath
Assess if feels
pain or
swelling in
legs and cool
or pale arm or
leg
Check for
sudden
confusion,
trouble
speaking, or
trouble
on
Seizures
NAME
OF
DRUG
MECHANIS
M OF
ACTION
CLASSIFICA
TION
DOSAGE
INDICATION
CONTRAIND
ICA-TION
ADVERS
EFFECT
understandin
g others
speech
Monitor if
feels sudden
trouble in
walking,
dizziness, loss
of balance or
coordination
Monitor BP
before the
therapy
NURSING
RESPONSIBILITY
BRAND
NAME:
Nexium
GENERI
C
NAME:
Esomep
razole
Reduce
s
gastric
acid
secreti
on and
decrea
ses
gastric
acidity
Proton
Pump
Inhibitor
s
40g
o0ne
cap
once a
day
Gastroes
ophageal
reflux
disease
(GERD)
To reduce
risk of
gastric
ulcer in
patients
receiving
continuo
us
NSAIDS
therapy
To
eliminate
H. pylori
Contrain CNS:
headach
dicated
e
in
GI:
patient
Abdomi
with
nal pain,
hepatic
constipa
insufficie
tion,
ncy and
diarrhea
in
, dry
pregnant
mouth,
and
flatulen
lactating
ce,
mother
nausea,
vomitin
g
Give drug at
least 1 hour
before meals
If via NGT
open capsule
and empty the
granules into a
60 ml syringe
Monitor
patients for
rash or signs
and symptoms
of
hypersensitivit
y
Monitor liver
function test
Instruct
patient to take
drug exactly
as prescribe
Advise patient
that antacids
can be used
while taking
drug unless
otherwise
directed by
prescriber
NAME
OF
DRUG
MECHANIS CLASSIFICATI
ON
M OF
ACTION
DOSAGE
INDICATIO
N
CONTRAINDI
CA-TION
ADVERS
EFFECT
Warm the
patient not to
chew or crust
pellet because
this can
inactivate the
drugs
NURSING
RESPONSIBILITY
BRAND
NAME:
Caltrate
600
Os-Cal
500
Tums
Extra
Tums
Chewy
delight
GENERI
C
NAME:
Calcium
Carbona
te
Reduce Calcium
s total
Salt
acid
load in
GI
tract,
elevat
es
gastric
pH to
reduce
pepsin
activit
y,
strengt
hens
gastric
mucos
al
barrier
, and
increas
es
esopha
geal
sphinct
er
tone.
500
mg
tab
three
times
a day
Acid
indigest
ion,
calcium
supple
ment
Contraindi CNS:
Headac
cated to
he,
patients
irritabilit
with
y,
increased
weakne
calcium
ss
level in
GI:
blood
Nausea,
and/or
constipa
increased
tion,
calcium in
flatulen
urine,
ce,
kidney
rebound
stone,
hyperac
increased
idity
level of
vitamin D,
and
phosphate
in blood.
Assess for
nausea and
vomiting,
anorexia,
thirst,
severe
constipation
Asses for
heartburn,
indigestion,
abdominal
pain
Monitor VS
especially BP
and PR
Monitor
serum
calcium
before
treatment
Record
amount and
consistency
of stool
Watch for
evidence of
hyperkalemia
NAME
OF
MECHANIS
M OF
CLASSIFICATI
ON
DOSAGE
INDICATION
CONTRAINDI
CA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
DRUG
BRAND
NAME:
Catapre
sCatapr
e-TTS
Jenloga
GENERI
C NAME:
Clonidin
e
ACTION
Unknow
n.
Thought
to
stimulat
e alpha
recertor
and
inhibit
the
central
vasomo
tor
centers,
decreas
ing
sympha
titic
outflow
to the
heart,
kidney,
and
periphe
ral
vasculat
ure and
lowerin
g
periphe
Centrally
acting
alpha
agonist
75mcg/
tab
once a
day
Essential
and renal
hypertensi
on
Severe
cancer
pain
Dysmenor
rhea
Contraind
icated to
patients
with
severe
coronary
insufficie
ncy,
conductio
n
disturban
ce, recent
MI,
cerebrova
scular
disease,
CRF, or
impaired
liver
function
CNS:
Drowsine
ss,
dizziness
,
sedation,
weaknes
s,
fatigue,
agitation
,
depressi
on
CV:
Bradycar
dia,
orthostat
ic
hypotens
ion
GI:
Constipa
tion, dry
mouth,
anorexia
GU:
Urine
retention
,
impotenc
e
Observe
patient to
tolerance the
drugs
therapeutic
effect, which
may require
increase
dosage
Monitor BP
AND PR
frequently
Advise patient
that stopping
drug abruptly
may cause
severe
rebound high
BP
Tell patient to
take the last
dose
immediately
before
bedtime
ral
vascula
r
resistan
ce, BP
and HR
NAME
OF
MECHANIS
M OF
Skin:
Pruritus,
rash
CLASSIFICATI
ON
DOSAGE
INDICATION
CONTRAIND
ICA-TION
ADVERS
EFFECT
Inform patient
that dizziness
upon standing
can be
minimized by
rising slowly
from sitting or
lying position
Advise patient
to avoid
sudden
position
changes
NURSING
RESPONSIBILITY
DRUG
ACTION
BRAND
NAME:
Aturnin
HMGCoA
reduct
ase
inhibito
r;
inhibits
ratelimiting
step in
cholest
erol
biosynt
hesis
by
compe
titively
inhibiti
ng
HMGCoA
reduct
ase
GENERI
C
NAME:
Atorvas
tatin
HMGCoA
reductas
e
inhibitor
10mg/
tab
one
tab
/day
Adjunct
to diet in
primary
hyperchol
esterole
mia
(heterozy
gous
familial
and
nonfamili
al) and
mixed
dyslipide
mia
(Types IIa
and IIb)
to reduce
total-C,
LDL-C,
apo B
and TG,
and to
increase
HDL-C.
To reduce
risk of MI,
Contrain
dicated
in
patients
with
severe
liver
problem
s, who
are
taking
HIV
protease
inhibitor
s, during
pregnan
cy and
breastfe
eding,
and
hyperse
nsitivity.
CNS:
Headac
he,
insomia
CV:
Peripher
al
edema
GI:
Abdomi
nal
pain ,
constipa
tion,
nausea
GU:
UTI
RESPIR
ATORY:
bronchit
is
Skin:
rash
Teach patient
about proper
dietary
management
, weight
control, and
exercise
Warm patient
to avoid
alcohol
Tell patient to
inform
prescriber of
adverse
reaction such
as fever
Advise
patient that
drug can be
taken at any
time of day,
without
regard to
meals
Stroke
and
angina
NAME
OF
MECHANIS
M OF
CLASSIFICA
TION
DOSAGE
INDICATION
CONTRAIND
ICA-TION
ADVERS
EFFECT
NURSING
RESPONSIBILITY
DRUG
ACTION
BRAND
NAME:
Levaqui
n
Inhibits
bacteri
al; DNA
gyrase
and
preven
t DNA
replicat
ion,
transcr
iption,
rte4pai
r, and
recom
binatio
n in
suscep
tible
bacteri
a
GENERI
C
NAME:
Levoflo
xacin
Flouroqu
inolone
500m
g/ tab
One
tab
OD
times
7 days
Acute
bacterial
sinusitis
caused
by
Strptococ
us
Pneumoni
ae
Communi
ty
acquires
pneumon
ia from S.
Pneumoni
ae
Acute
pelvic
inflamma
tory
Mild to
modrate
UTI
Contrain
dicated
in
patient
with
hyperse
nsitivity
to drug
CNS:
Seizure,
dizzines
s,
headach
e,
insomni
a
CV:
Chest
pain,
palpitati
ons
GI:
Abdomi
nal pain,
constipa
tion,
diarrhea
,
flatulen
ce
REPIRAT
ORY:
Allergic
pneumo
nitis
SKIN:
Monitor
glucose level
and renal,
hepatic and
hematopoietic
blood studies
Tell to patient
to take drus as
prescribe,
even if signs
and symptoms
disappear
Advise patient
to take drug
with plenty of
fluids
Warn patient
to avoid
hazardous
activities
Advise the
patient to
avoid
excessive
sunlight and
Photose
nsitivoty
,
pruritus,
rash
wear
protective
clothing when
out doors
Instruct the
patient to
notify
prescriber of
loose stool or
diarrhea